1026787-89-2 Usage
Uses
Used in Pharmaceutical Industry:
2,4-dichloro-6-isopropoxypyriMidine is used as a chemical intermediate for the synthesis of various pharmaceutical products. Its unique structure and functional groups make it a valuable building block in the development of new drugs and therapeutic agents.
Used in Agricultural Industry:
2,4-dichloro-6-isopropoxypyriMidine is used as a potential herbicide for controlling the growth of certain weed species. Its effectiveness in inhibiting weed growth makes it a valuable tool in agricultural applications, helping to improve crop yields and reduce the need for manual weed control.
Used in Chemical Production:
2,4-dichloro-6-isopropoxypyriMidine is also used in the production of other chemicals, serving as a key component in the synthesis of various organic compounds. Its versatility and reactivity make it an important building block in organic synthesis, contributing to the development of new chemical products and materials.
Safety Considerations:
Due to its moderate to low toxicity, 2,4-dichloro-6-isopropoxypyriMidine should be handled with care to avoid skin and eye irritation. Proper safety measures, such as wearing protective clothing and using appropriate handling equipment, should be taken to minimize potential health risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 1026787-89-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,6,7,8 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1026787-89:
(9*1)+(8*0)+(7*2)+(6*6)+(5*7)+(4*8)+(3*7)+(2*8)+(1*9)=172
172 % 10 = 2
So 1026787-89-2 is a valid CAS Registry Number.
1026787-89-2Relevant academic research and scientific papers
INDOLE AHR INHIBITORS AND USES THEREOF
-
Paragraph 00543-00544, (2018/11/22)
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
De novo design of nonpeptidic compounds targeting the interactions between interferon-α and its cognate cell surface receptor
Bello, Angelica M.,Bende, Tanushree,Wei, Lianhu,Wang, Xiaoyang,Majchrzak-Kita, Beata,Fish, Eleanor N.,Kotra, Lakshmi P.
, p. 2734 - 2743 (2008/12/22)
Type 1 interferons (IFN) bind specifically to the corresponding receptor, IFNAR. Agonists and antagonists for IFNAR have potential therapeutic value in the treatment of viral infections and systemic lupus erythematosus, respectively. Specific sequences on
